ILMNIllumina Inc.
Chart data are delayed by 15 minutes.
Main metrics
Providers
All 2 issuers →Chains
All 11 chains →About ILMN
Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious diseases, reproductive health, and molecular diagnostics. Illumina also provides sequencing consumables, instruments, software, and support services that help laboratories generate, interpret, and manage genomic data. The company serves customers including academic institutions, genomic research centers, hospitals, pharmaceutical and biotechnology companies, and clinical laboratories. Headquartered in San Diego, California, and founded in 1998, Illumina plays a central role in making genomic analysis more widely accessible for research and healthcare applications.
Valuation
Profitability
Balance sheet
Trading
No dividend has been recorded for this asset.
| Date | Type | Details |
|---|---|---|
| Jun 25, 2024 | Stock split | 1028-for-10001 share → 1028 shares |
| Sep 23, 2008 | Stock split | 2-for-11 share → 2 shares |
Splits, mergers and other corporate actions appear here. How each issuer reflects them on-chain varies by product.








